A drug that decreases the activity of dopamine within the dorsolateral prefrontal cortex would be expected to

Question

Quizplus · Accepted Answer

The dorsolateral prefrontal cortex is associated with cognitive processes such as attention, working memory, and decision making, and dopamine plays an important role in these processes. Decreasing dopamine activity in this area could therefore lead to both positive and negative symptoms of schizophrenia, as both types of symptoms are associated with dysfunctions in the prefrontal cortex. Positive symptoms, such as hallucinations and delusions, may be caused by an overactivity of dopamine in other brain regions, such as the striatum, while negative symptoms, such as apathy and social withdrawal, may be caused by a hypoactivity of dopamine in the prefrontal cortex. Therefore, decreasing dopamine activity in this area may improve some symptoms of schizophrenia, but could also lead to others.

A Drug That Decreases the Activity of Dopamine Within the Dorsolateral